Literature DB >> 10781116

Randomised double-blind comparison of fentanyl, mivacurium or placebo to facilitate laryngeal mask airway insertion.

E W Cheam1, P T Chui.   

Abstract

In a double-blind randomised study, we compared conditions during insertion of the laryngeal mask airway in 150 patients who received either fentanyl 1 microg.kg-1, mivacurium 0.04 mg.kg-1 or normal saline, before induction of anaesthesia with propofol 2 mg.kg-1. Insertion conditions, including mouth opening, swallowing, gagging or coughing, head or limb movement and ease of insertion, were each graded using a three-point scale. The median (interquartile range) summed insertion scores were more favourable with the use of fentanyl [8.0 (7.0-9.0)] and mivacurium [7.5 (6.8-8.3)] than with normal saline [9.0 (7.8-10.3); p < 0.01]. Fentanyl and mivacurium decreased swallowing and head or limb movement, and mivacurium improved mouth opening. Insertion conditions were similar between fentanyl and mivacurium, while both prolonged apnoea. Fentanyl and mivacurium are equally effective in facilitating insertion of the laryngeal mask airway following anaesthetic induction with propofol.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781116     DOI: 10.1046/j.1365-2044.2000.01214.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  16 in total

1.  Comparative evaluation of ketamine - propofol, fentanyl - propofol and butorphanol-propofol on haemodynamics and laryngeal mask airway insertion conditions.

Authors:  Asha Gupta; Sarabjit Kaur; Joginder Pal Attri; Nisha Saini
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-01

2.  Comparison of Dexmedetomidine-Propofol versus Fentanyl-Propofol on Insertion Conditions of Proseal Laryngeal Mask Airway.

Authors:  Shalaka Sandeep Nellore; Abhijeet Dattatray Waychal; Preeti Sachin Rustagi
Journal:  J Clin Diagn Res       Date:  2016-11-01

3.  Randomized double-blind comparison of ketamine-propofol and fentanyl-propofol for the insertion of laryngeal mask airway in children.

Authors:  Ranju Singh; Madhur Arora; Homay Vajifdar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-01

4.  What is new in critical illness and injury science? Benefits of co-induction anesthesia in supraglottic airway management.

Authors:  Sujata Chaudhary
Journal:  Int J Crit Illn Inj Sci       Date:  2012-01

5.  Comparison of ketamine with fentanyl as co-induction in propofol anesthesia for short surgical procedures.

Authors:  Ritu Goyal; Manpreet Singh; Jaiprakash Sharma
Journal:  Int J Crit Illn Inj Sci       Date:  2012-01

6.  Effects of addition of ketamine, fentanyl and saline with Propofol induction on hemodynamics and laryngeal mask airway insertion conditions in oral clonidine premedicated children.

Authors:  Tanmoy Ghatak; Dinesh Singh; Rajni Kapoor; Jaishree Bogra
Journal:  Saudi J Anaesth       Date:  2012-04

7.  A clinical comparison of ketofol (ketamine and propofol admixture) versus propofol as an induction agent on quality of laryngeal mask airway insertion and hemodynamic stability in children.

Authors:  Gamal T Yousef; Khalid M Elsayed
Journal:  Anesth Essays Res       Date:  2013 May-Aug

8.  Performance of size 1 I-gel compared with size 1 ProSeal laryngeal mask in anesthetized infants and neonates.

Authors:  Gulay Erdogan Kayhan; Zekine Begec; Mukadder Sanli; Ender Gedik; Mahmut Durmus
Journal:  ScientificWorldJournal       Date:  2015-02-22

9.  Low-dose Succinylcholine to Facilitate Laryngeal Mask Airway Insertion: A Comparison of Two Doses.

Authors:  Leah R George; Raj Sahajanandan; Sarah Ninan
Journal:  Anesth Essays Res       Date:  2017 Oct-Dec

10.  Comparison of Propofol and Ketamine-Propofol Mixture (Ketofol) on Laryngeal Tube-Suction II Conditions and Hemodynamics: A Randomized, Prospective, Double-Blind Trial.

Authors:  Ulku Ozgul; Zekine Begec; Kalender Karahan; Mehmet Ali Erdogan; Mustafa Said Aydogan; Cemil Colak; Mahmut Durmus; M Ozcan Ersoy
Journal:  Curr Ther Res Clin Exp       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.